EDIT: The "sell-the-news" crowd missed that this announcement is for a topical compound that means a short duration trial as compared to B-OM for oncology. Like B-ABSSSI, it either works in a few days or it doesn't.
EDIT: This is not meant as a jab at Amatuer17, rather it is a jab at this morning's trash talkers right from the start.
Hey shortie, the next leg of the CTIX rally is about to eat your margin for lunch.